AdvaMed Position Statement Regarding Transition to National Reimbursement Codes
This AdvaMed position statement is intended to provide clarity about the transition away from the acronyms NDC/NHRIC to NRC, including rationale and implications.
Resource Library
Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.
Filter By:
AdvaMed Response to Senate HELP Committee Regarding Reauthorization of Pandemic All-Hazards Preparedness Act
On March 29, AdvaMed responded to the Senate HELP Committee’s request for information on policy priorities for the reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA).
Fact Sheet: EtO Sterilization Prevents Infection
Each year in the U.S., ethylene oxide sterilizes 20 billion medical devices, which are critical to preventing serious, even life-threatening, infections.
AdvaMed Comment Letter to OIG – January 27, 2023
AdvaMed responded to HHS OIG’s annual solicitation of proposals for new and modified safe harbors and special fraud alerts.
Regulations and Reimbursement of Software as a Medical Device in Europe- Part1
This publication series explores “Software as a Medical Device (SaMD),” its challenges and the ways regulatory bodies try to address them, as well as the expected development of regulations related…
Listen to AdvaMed's Podcast
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
A Framework for Comprehensive Assessment of the Value of Diagnostic Tests
It is critical for diagnostic test developers to demonstrate the value of their tests to a variety of stakeholders. This framework serves as a resource for members to assess and…
A Framework for Comprehensive Assessment of Medical Technologies
AdvaMed launched a Strategic Value Initiative to develop principles and an approach for assessing the value of medical technologies that can be adopted by medtech companies, health systems, payers, and…
Keeping Pace with Real-World Evidence: Evolving Software Regulations and the Growing Application of Artificial Intelligence
This white paper explores the increasing spotlight on the use of real world evidence, what regulators are looking for, and how AI-powered applications are rising in the field of digital…
Future of Medtech: Define New Markets Before They Define You
This report from PwC presents three growth strategies to empower medtech companies to win in this competitive and rapidly changing environment.